Literature DB >> 1392183

Recurrent intracranial hemorrhagic episodes in hepatopulmonary syndrome.

H Shijo1, H Sasaki, K Nishimaru, M Okumura.   

Abstract

A 57-year-old woman with hepatopulmonary syndrome was treated for eight years. Severe hypoxemia continued and her erythrocytosis was slowly progressive. Two episodes of intracranial hemorrhagic attack had occurred during the follow-up period and the patient died due to multiple organ failure after the second intracranial hemorrhage. Her autopsy findings confirmed not only established liver cirrhosis associated with intracranial hemorrhage but also the marked dilatation of pulmonary capillaries in both lungs. These findings suggest that secondary erythrocytosis in hepatopulmonary syndrome can be contributed to fatal intracranial vascular accidents. The containment of erythrocytosis should be considered in these patients.

Entities:  

Mesh:

Year:  1992        PMID: 1392183     DOI: 10.2169/internalmedicine.31.786

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Multiple recurrent intracerebral hemorrhages and hepatopulmonary syndrome.

Authors:  Andreia Carvalho; Marta Rodrigues; Mariana Rocha; Joana Nunes; André Cunha; Henrique Costa; Pedro Barros
Journal:  Neurol Clin Pract       Date:  2019-08

3.  An Unusual Case of Hepato-Pulmonary-Cutaneous Syndrome With Giant Spider Angioma and Intracranial Bleed.

Authors:  Shekhar Singh Jadaun; Sanjiv Saigal; Ana Hasnain; Mukesh Kumar; Dhiraj Agrawal; Shweta Singh; Dibyajyoti das; Shaleen Agarwal; Subhash Gupta
Journal:  J Clin Exp Hepatol       Date:  2021-12-30

Review 4.  Pulmonary vascular complications of liver disease.

Authors:  Jason S Fritz; Michael B Fallon; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.